LONDON, February 6, 2017 /PRNewswire/ --

Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR)

The global interventional cardiology market is expected to grow at a CAGR of 11.1% in the first half of the forecast period and CAGR of 16.9% in the second half of the forecast period. The market is expected to grow at a CAGR of 15.0% from 2017 to 2027. The market is estimated at $13,920m in 2021 and $35,537m in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 225-page report you will receive 111 charts - all unavailable elsewhere.

The 225-page report provides clear detailed insight into the global interventional cardiology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

• Global Interventional Cardiology Market forecasts from 2017-2027

• Percutaneous Coronary Intervention (PCI) submarket forecasts from 2017-2027, further segmented into:
- Drug-eluting Stents (DES)
- Bare Metal Stents
- Bioresorbable Stents

This section also discusses the leading products, competitive landscape, market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for PCI in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.

• Transcatheter Aortic Valve Implantation (TAVI/TAVR) from 2017-2027
This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TAVI/TAVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

• Trans Mitral Valve Implantation (TMVR) submarket forecasts from 2017-2027
This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TMVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.

• Interventional Cardiology Leading National Market forecasts from 2017-2027 covering the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China, India and the Rest of the World (RoW)

Each country is further segmented into PCI, TAVI and TMVR. 

• Assessment of selected leading companies that hold major market shares in the interventional cardiology market

• SWOT and STEP analysis of the global interventional cardiology market

Visiongain's study is intended for anyone requiring commercial analyses for the Global Interventional Cardiology Market. You find data, trends and predictions.

Buy our report today Global Interventional Cardiology Market 2017-2027: Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR).

To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100

Or click on : https://www.visiongain.com/Report/1786/Global-Interventional-Cardiology-Market-2017-2027

List of Companies and Organisations Mentioned in the Report 

3mensio Medical Imaging

Abbott

Accucinch

Alvimedica

Amaranth Medical

Aperture Venture Partners

Arterial Remodelling Technologies

B.Braun

Balton

Biosensors International

Biotronik

Boston Scientific Group

British Heart Foundation

Caisson

Cardiac Dimensions

CardiAQ

Cardica

Cardiosolutions

Centre for Disease and Prevention Control (CDC)

Centres for Medicare & Medicaid Services

Cordis

Direct Flow Medical

Edwards Lifesciences

Elixir Medical Corporation

Emory University

European Society for Cardiology

FDA

HighLife

JenaValve

JW Medical Systems

Kardium

Kyoto Medical Planning

Lepu Medical Technology

Life Science Partners

Mardil Medical

Medfavour Medical Co., Ltd.

Medtronic

Micell Technologies

Microport Scientific

Milipede

Ministry of Health Labor and Welfare (MHLW)

Mitralign Inc.

Mitralix

MitrAssist

MVRx

NCSI

Neovasc

OrbusNeich Medical, Inc.

Paieon Inc

Pharmaceuticals and Medical Devices Agency (PDMA)

Phillips

Reva Medical

Sahajanand Medical Technologies Pvt.

Shanghai MicroPort Medical (Group) Co., Ltd.

Siemens AG

Singapore Heart Foundation

St Jude Medical

Surmodics Inc.

Sysmetis

Tendyne Holdings, Inc.

Terumo

The Health Science Authority (HSA)

The Medical Services Advisory Committee (MSAC)

TransCardiac

Valtech Cardio

Vascular Concepts

Venus Medtech Inc.,

WHO

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

SOURCE Visiongain Ltd